[HTML][HTML] Targeting the immune microenvironment in the treatment of head and neck squamous cell carcinoma
HC Wang, LP Chan, SF Cho - Frontiers in Oncology, 2019 - frontiersin.org
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive solid tumor, with
a 5-year mortality rate of~ 50%. The development of immunotherapies has improved the …
a 5-year mortality rate of~ 50%. The development of immunotherapies has improved the …
Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
HC Wang, LP Chan, SF Cho - Frontiers in oncology, 2019 - pubmed.ncbi.nlm.nih.gov
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive solid tumor, with
a 5-year mortality rate of~ 50%. The development of immunotherapies has improved the …
a 5-year mortality rate of~ 50%. The development of immunotherapies has improved the …
[引用][C] Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
HC Wang, LP Chan, SF Cho - Frontiers in Oncology, 2019 - cir.nii.ac.jp
Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous
Cell Carcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
Cell Carcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
HC Wang, LP Chan, SF Cho - Head & Neck Cancer and …, 2021 - books.google.com
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive solid tumor, with
a 5-year mortality rate of∼ 50%. The development of immunotherapies has improved the …
a 5-year mortality rate of∼ 50%. The development of immunotherapies has improved the …
[HTML][HTML] Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
HC Wang, LP Chan, SF Cho - Frontiers in Oncology, 2019 - ncbi.nlm.nih.gov
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive solid tumor, with
a 5-year mortality rate of~ 50%. The development of immunotherapies has improved the …
a 5-year mortality rate of~ 50%. The development of immunotherapies has improved the …
Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma.
HC Wang, LP Chan, SF Cho - Frontiers in Oncology, 2019 - europepmc.org
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive solid tumor, with
a 5-year mortality rate of~ 50%. The development of immunotherapies has improved the …
a 5-year mortality rate of~ 50%. The development of immunotherapies has improved the …
Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma.
HC Wang, LP Chan, SF Cho - Frontiers in Oncology, 2019 - europepmc.org
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive solid tumor, with
a 5-year mortality rate of~ 50%. The development of immunotherapies has improved the …
a 5-year mortality rate of~ 50%. The development of immunotherapies has improved the …